Welcome to our dedicated page for Pheton Holdings SEC filings (Ticker: PTHL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Pheton Holdings Ltd (PTHL), a Cayman Islands healthcare solution provider focused on treatment planning systems for brachytherapy and related products and services. As a foreign private issuer, the company files an annual report on Form 20-F and furnishes current reports on Form 6-K to disclose financial information and material corporate events.
Through Pheton’s SEC filings, readers can review unaudited interim condensed consolidated financial statements, which have been furnished on Form 6-K for specified periods. These filings include financial statements and accompanying notes, as well as Inline XBRL data files that structure key financial information for analysis.
The company’s 6-K reports also document corporate governance and organizational changes, such as the appointment and resignation of independent directors, the engagement of an independent registered public accounting firm, and the furnishing of notices and proxy statements for its annual general meeting of shareholders. Certain filings include updated memorandum and articles of association, reflecting changes associated with the corporate name iTonic Holdings Ltd.
Investors can find details on capital markets and transaction activity in Pheton’s filings. The company has reported its initial public offering on the Nasdaq Capital Market, advisory services agreements related to mergers and acquisitions strategies, and stock purchase agreements to acquire equity interests in healthcare technology targets, including iTonic Corporation and a company established to develop and commercialize advanced medical device technologies. These reports describe consideration structures involving newly issued Class A ordinary shares and warrants, as well as regulatory exemptions relied upon for unregistered sales of securities.
Filings further disclose Nasdaq listing compliance matters, including a notice from the Nasdaq Listing Qualifications Department regarding non-compliance with the minimum bid price requirement and the associated compliance period. In addition, a current report describes Pheton’s plan to change its corporate name to iTonic Holdings Ltd and its Nasdaq ticker symbol from "PTHL" to "ITOC," explaining that these changes reflect a new business strategy and future development plans.
On Stock Titan, these SEC documents are updated as they are made available through EDGAR, and AI-powered tools can help summarize lengthy filings such as Form 20-F annual reports or detailed Form 6-K exhibits. Users can quickly identify key points about Pheton’s financial condition, acquisitions, governance changes, and listing status, and can also review disclosures related to equity issuances and warrant arrangements. For those researching the historical PTHL ticker and the transition to ITOC, this filings archive offers a structured view of how the company’s regulatory record has developed over time.
iTonic Holdings Ltd director Zhang Pengfei filed an initial Form 3, which is a required statement of beneficial ownership for company insiders. This filing does not report any stock purchases, sales, option exercises, or other transactions; it simply establishes Zhang’s status as a reporting director at iTonic Holdings.
iTonic Holdings Ltd executive Li Zhixin, the company’s CFO, has filed an initial Form 3 as an officer of the company. The provided data does not show any insider transactions or derivative positions, indicating this filing functions mainly as a baseline ownership disclosure.
Pheton Holdings Ltd is furnishing unaudited interim condensed consolidated financial statements for the six months ended June 30, 2025, in a report as a foreign private issuer. These statements, attached as Exhibit 99.1, cover the six-month periods ended June 30, 2024 and 2025 and provide a detailed view of the company’s mid-year financial position and operating results.
Pheton Holdings Ltd has appointed Fortune CPA, Inc. as its independent registered public accounting firm under an engagement letter dated December 8, 2025. The appointment was approved by the company’s audit committee of the board of directors, confirming board-level authorization of Fortune CPA’s role as the external auditor for the company.
Pheton Holdings Ltd (PTHL) submitted a Form 6-K related to its 2025 Annual General Meeting of Shareholders. The filing primarily serves to furnish key shareholder materials for that meeting.
The submission includes the notice and proxy statement for the annual meeting, as well as the Third Amended and Restated Memorandum of Association and Third Amended and Restated Articles of Association of iTonic Holdings Ltd. The report is signed by Chief Executive Officer and Chairman Jianfei Zhang on behalf of the company.
Pheton Holdings Ltd reported governance changes. Independent director Edward C Ye resigned effective immediately for personal reasons, with no disagreement cited. The board appointed Richard Wee Yong Seow as an independent director, and named him to the Audit, Nomination & Corporate Governance, and Compensation Committees. He will replace Swee Leng Seng as chair of the Compensation Committee, while Mr. Swee Leng Seng becomes chair of the Audit Committee. The Company states Mr. Seow meets Nasdaq and SEC independence standards, and Mr. Swee Leng Seng is an SEC-defined “audit committee financial expert.” The Company entered into an indemnification agreement with Mr. Seow.
Pheton Holdings Ltd (PTHL) reported it received a Nasdaq notice that its Class A ordinary shares failed the minimum bid price requirement under Listing Rule 5550(a)(2) after trading below $1.00 for 30 consecutive business days. The notice does not trigger immediate delisting, and the shares continue trading under “PTHL.”
The company has 180 calendar days, until April 20, 2026, to regain compliance. If the closing bid is at least $1.00 for a minimum of 10 consecutive business days during this period, Nasdaq will confirm compliance. If compliance is not regained by that date, Pheton may qualify for an additional 180‑day grace period if it meets other Nasdaq Capital Market initial listing standards (except bid price) and notifies Nasdaq of its plan to cure, which may include a reverse stock split.
Pheton Holdings Ltd has entered a five-year Advisory Services Agreement with Comane International Group Ltd to support mergers and acquisitions and broader corporate development work. The advisor will help with market research, capital restructuring plans, deal structuring, valuation, due diligence, regulatory communications, and coordination with other professionals.
As compensation, Pheton agreed to issue Warrants to purchase up to 4,000,000 Class A ordinary shares at an exercise price of US$0.80 per share, expiring five years from issuance. The Warrants cannot be exercised until six months after the Agreement and only with written consent from the Chief Executive Officer, who must determine in good faith, after consulting the Board if needed, that the services have been satisfactorily performed. Either party can terminate the Agreement with 30 days’ notice, in which case unexercised Warrants are returned and cancelled, and any exercised but unearned portion is subject to clawback treatment defined in the Agreement.
Pheton Holdings Ltd has agreed to acquire 30% of Geri-Safe, Ltd. through a stock purchase agreement. Pheton will pay for this minority stake by issuing 4,000,000 newly issued Class A ordinary shares to the selling shareholders.
Geri-Safe develops advanced medical device technologies, operates with an asset-light model, holds FDA 510(k) Class I clearance obtained in 2019, and owns a patent portfolio covering hardware, software and related designs. The new Pheton shares, related warrants, and the Class A ordinary shares issuable upon warrant exercise will be issued as unregistered securities under exemptions including Section 4(a)(2), Rule 506(b) of Regulation D, and Regulation S. Closing depends on customary conditions and is subject to risks such as possible failure to complete the transaction, legal proceedings, regulatory approvals and potential termination of the agreement.